Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
05/2003
05/07/2003EP1308170A2 Dried blood factor composition comprising trehalose
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1308155A2 Injectable solution containing a colloid of iron and shark cartilage-derived chondroitin sulfate
05/07/2003EP1307588A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF
05/07/2003EP1307568A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
05/07/2003EP1307566A2 Mitogen activated kinase
05/07/2003EP1307491A1 Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307444A2 Substituted heterocyclic amides
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307438A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
05/07/2003EP1307432A1 Cyclic oxyguanidine protease inhibitors
05/07/2003EP1307430A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/07/2003EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
05/07/2003EP1307183A2 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
05/07/2003EP1152004B1 Phosphonic acid derivatives having carboxypeptidase B inhibitory action
05/07/2003EP1147110B1 Pyrazino(aza)indole derivatives
05/07/2003EP1140825B1 Melatonin derivatives and medicine containing same
05/07/2003EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0858464B1 Thrombin inhibitors
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0792270B1 Use of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxy chroman (LLU-alpha)
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0709386B1 Fused benzazepine derivative and pharmaceutical composition containing the same
05/07/2003CN1416348A Modified factor VIII
05/07/2003CN1416339A IL-8 receptor antagonsts
05/07/2003CN1415367A Bill of eliminating water and detumescence as well as its preparation method
05/07/2003CN1415356A Medicament containing snail powder
05/07/2003CN1415347A Formula for curing anaphylactoid purpura
05/07/2003CN1415329A Compund paste of donkey-skin gelatin for enriching the blood
05/07/2003CN1415328A Stilbene paste capsule of rising white blood cell for curing disease of leucopenia
05/07/2003CN1415311A Novel preparation of ferrisodium pyrophosphate
05/07/2003CN1415296A Compsn. containing ligustrazine, penetrating skin paste agent of igustrazine and its preparation method
05/07/2003CN1415289A Novel preparation of ethylenediamine tetraacetic acid ferro (EDTAferro)
05/07/2003CN1107520C Oral liquid of gingko
05/07/2003CN1107502C Prepn. method for medicinal compsn. contg. hydrogonated pyridine derivative as active components
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559159 Kappa opioid receptor ligands
05/06/2003US6559147 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example
05/06/2003US6558707 Micronized particles in carrier such as a purified, micro-crystalline or alkylated cellulose
05/06/2003US6558703 Porous hydroxyapatite particles as carriers for drug substances
05/06/2003US6558662 Treatment of hematologic disorders
05/02/2003EP1306368A2 3,4-dihydro-1H-naphtalene derivatives as a highly selective cyclooxygenase-2 inhibitor
05/02/2003EP1306083A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
05/02/2003EP1305434A2 A human disintegrin protein
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305316A2 Azabicyclic derivatives and their therapeutic use
05/02/2003EP1305313A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors
05/02/2003EP1305309A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis
05/02/2003EP1305306A2 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305295A1 Imidazole derivatives
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
05/02/2003EP1305291A1 3-substituted isoquinolin-1-yl derivatives
05/02/2003EP1305053A1 A medicinal aerosol formulation
05/02/2003EP1305027A2 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
05/02/2003EP1305025A1 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative
05/02/2003EP1305007A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
05/02/2003EP1305004A1 Embolization using carbon coated particles
05/02/2003EP1221939A4 Ortho ester lipids
05/02/2003EP1185516B1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
05/02/2003EP1032579B1 Carbohydrate derivatives
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/02/2003EP0802983B1 Expression of urokinase plasminogen activator inhibitors
05/02/2003EP0738150B1 Bicyclic fibrinogen antagonists
05/02/2003EP0714435B1 Pro-urokinase mutants
05/02/2003CA2411015A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/02/2003CA2411011A1 5-heteroatom-substituted pyrazoles
05/02/2003CA2411009A1 Heterocyclo-alkylsulfonyl pyrazoles
05/02/2003CA2410466A1 Hydrazinyl and nitrogen oxide pyrazoles
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035886A2 Method for preparing heparin from mast cell cultures
05/01/2003WO2003035861A2 Thrombin-cleavable chimeric proteins
05/01/2003WO2003035835A2 Glycoprotein compositions
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035670A2 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035640A1 Pyrimidone compounds and pharmaceutical compositions containing the same
05/01/2003WO2003035635A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them
05/01/2003WO2003035133A1 Stents
05/01/2003WO2003035110A1 Treating vascular disease by inhibiting toll-like receptor-4
05/01/2003WO2003035079A1 A combination product comprising melagatran and dexamethasone
05/01/2003WO2003035075A1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003035064A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
05/01/2003WO2003035062A1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
05/01/2003WO2003035029A1 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/01/2003WO2003034987A2 Androgen receptor modulators and methods of use thereof
05/01/2003WO2003000242A3 Method for the treatment of lymphedema using guaifenesin
05/01/2003WO2002098444A3 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002074292A3 Hormone replacement therapy
1 ... 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 ... 671